Iron accumulation in multiple sclerosis: An early pathogenic event

Expert Review of Neurotherapeutics

Volumn 13, Issue 3, 2013, Pages 247-250

  Levine, Steven M ^a   Bilgen, Mehmet ^b   Lynch, Sharon G ^c  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b ERCIYES UNIVERSITY   (Turkey)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

caudate; clinically isolated syndrome; globus pallidus; iron; multiple sclerosis; pulvinar; putamen; susceptibility weighted imaging

Indexed keywords

IRON;

ARTICLE; CAUDATE NUCLEUS; GLOBUS PALLIDUS; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PULVINAR; PUTAMEN;

EID: 84874616379     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.13.14     Document Type: Article

References (20)

1. Drayer B, Burger P, Hurwitz B, Dawson D, Cain J. Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? AJR. Am. J. Roentgenol. 149(2), 357-363 (1987).
2. Williams R, Buchheit CL, Berman NE, LeVine SM. Pathogenic implications of iron accumulation in multiple sclerosis. J. Neurochem. 120(1), 7-25 (2012).
3. Khalil M, Langkammer C, Ropele S et al. Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology 77(18), 1691-1697 (2011).
4. Ceccarelli A, Rocca MA, Neema M et al. Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis. Mult. Scler. 16(1), 39-44 (2010).
5. Hagemeier J, Weinstock-Guttman B, Bergsland N et al. Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structurespecific atrophy. AJNR. Am. J. Neuroradiol. 33(8), 1596-1601 (2012).
6. Al-Radaideh AM, Wharton SJ, Lim SY et al. Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in clinically isolated syndrome. Mult. Scler. doi:10.1177/1352458512465135 (2012) (Epub ahead of print).
7. Craelius W, Migdal MW, Luessenhop CP, Sugar A, Mihalakis I. Iron deposits surrounding multiple sclerosis plaques. Arch. Pathol. Lab. Med. 106(8), 397-399 (1982).
8. Adams CW. Perivascular iron deposition and other vascular damage in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 51(2), 260-265 (1988).
9. Campbell GR, Mahad DJ. Mitochondrial changes associated with demyelination: consequences for axonal integrity. Mitochondrion 12(2), 173-179 (2012).
10. Levi S, Rovida E. The role of iron in mitochondrial function. Biochim. Biophys. Acta 1790(7), 629-636 (2009).
11. Horowitz MP, Greenamyre JT. Mitochondrial iron metabolism and its role in neurodegeneration. J. Alzheimers Dis. 20(Suppl. 2), S551-S568 (2010).
12. LeVine SM. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res. 760(1-2), 298-303 (1997).
13. Williams R, Rohr AM, Wang WT et al. Iron deposition is independent of cellular inflammation in a cerebral model of multiple sclerosis. BMC Neurosci. 12, 59 (2011).
14. Hagemeier J, Yeh EA, Brown MH et al. Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis. Mult. Scler. doi:10.1177/1352458512459289 (2012) (Epub ahead of print).
15. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 52(3), 612-618 (2004).
16. Yao B, Li TQ, van Gelderen P, Shmueli K, de Zwart JA, Duyn JH. Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. Neuroimage 44(4), 1259-1266 (2009).
17. Haacke EM, Makki M, Ge Y et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J. Magn. Reson. Imaging 29(3), 537-544 (2009).
18. Onyszchuk G, LeVine SM, Brooks WM, Berman NE. Post-acute pathological changes in the thalamus and internal capsule in aged mice following controlled cortical impact injury: a magnetic resonance imaging, iron histochemical, and glial immunohistochemical study. Neurosci. Lett. 452(2), 204-208 (2009).
19. Koike T, Yang Y, Suzuki K, Zheng X. Axon and dendrite degeneration: its mechanisms and protective experimental paradigms. Neurochem. Int. 52(4-5), 751-760 (2008).
20. Ceccarelli A, Filippi M, Neema M et al. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis. Mult. Scler. 15(6), 678-686 (2009).